SANTA ROSA, Calif., July 21, 2015 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (Nasdaq:TRIV), manufacturer of the Ovation Prime® Abdominal Stent Graft System, today announced that the Company will release 2015 second quarter financial results after market close on Tuesday, August 4, 2015. Company management will host a conference call beginning at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) on Tuesday, August 4 to discuss those results and to answer questions.
Individuals interested in listening to the conference call may do so by dialing (844) 831-3024 for domestic callers, or (315) 625-6887 for international callers (Conference ID: 72827371), or from the webcast on the investor relations section of the Company’s website at: www.trivascular.com. The webcast will be available on the Company’s website for two weeks following the completion of the call.
About TriVascular Technologies, Inc. - TriVascular is a medical device company developing and commercializing innovative technologies to significantly advance minimally invasive treatment of abdominal aortic aneurysms. The company manufactures the Ovation Prime Abdominal Stent Graft System, the lowest profile FDA-approved EVAR system, which utilizes a novel, polymer-based sealing mechanism. TriVascular is based in Santa Rosa, California.
For more information visit www.trivascular.com
CONTACT: Media Contact: Vivek K. Jayaraman VP, Global Sales & Marketing (707) 543-8804 vivek.jayaraman@trivascular.com Investor Relations Contact: Westwicke Partners Jamar Ismail (415) 513-1282 jamar.ismail@westwicke.com
Help employers find you! Check out all the jobs and post your resume.
